|Articles|September 2, 2021

CDC Updates Salmonella Outbreak Related to Italian-Style Meats

The federal agency is advising people to not eat Fratelli Beretta brand prepackaged uncured antipasto trays.

The Centers for Disease Control and Prevention (CDC) is advising people to not eat the Fratelli Beretta brand prepackaged uncured antipasto trays. These trays can include uncured salami, prosciutto, coppa, or soppressata. They were sold nationwide and have “best by” dates on or before February 11, 2022.

Initially, the company, Fratelli Beretta, issued a recall on August 27 on just one of their products: The 24-oz. trays containing 2 12-oz packages of “Fratelli Beretta Uncured Antipasto Prosciutto, Soppressata, Milano Salami & Coppa with best by dates of AUG 27 21 through FEB 11 22 and it has a UPC code 073541305316.

The products subject to recall bear establishment number “EST. 7543B” printed on the packaging next to the best by date. These items were shipped to retail locations nationwide.

The CDC made the distinction to not eat any of the uncured deli meat trays.

There has been 36 reported illnesses, 12 hospitalizations, and no reported deaths. This has been reported in 17 states. The CDC pointed out that the outbreak may extend into other states because many people can recover without medical care and are not tested for Salmonella.

The investigation is ongoing to determine if additional products are linked to illness.


Related to this article

Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.